Published:
Xceed Molecular Features Ziplex(R) Automated Gene-Expression System at the Biomarker World Congress, Booth 16
WELLESLEY, Mass., May 16 /PRNewswire/ -- Xceed Molecular, a pioneer in the
development of cost-effective, easy-to-use gene-expression analysis systems,
announced that the company will feature its Ziplex Automated Gene-Expression
System at Biomarker World Congress, booth 16. Currently available for research
use only in the US andCanada, the Ziplex System is the first integrated
system for automated gene-expression analysis. It comprises an automated
hybridization workstation, TipChip consumable arrays, reagents, and
analysis/reporting software. Biomarker World Congress takes place May 19-21,
2008, at the Loews Philadelphia Hotel inPennsylvania.
"Translational research (the movement of existing gene-expression
biomarkers from basic science into routine clinical use for patient
diagnostics) -- and the ultimate goal of personalized medicine -- has been
hampered because the available technology to process microarrays is complex,
expensive, and time-consuming," said Xceed's President and CEO, David Deems.
"Results from traditional technology are also prone to unacceptable levels of
variability to meet the rigorous performance and quality-control needs of the
clinical-diagnostic laboratory. Xceed designed the Ziplex System with turnkey
functionality and significant advances in automation, array format, fluidics,
parallel sample processing, and analytics to minimize complexity, user
interaction, and variability between users and sites. Our goal: to make
routine molecular diagnostics easy, reproducible, and affordable to serve the
needs of both clinical research and clinical-diagnostic settings -- which
demand that results remain consistent even when samples are run by different
people, at different times, or in different sites."
Luncheon Workshop
Xceed is hosting a luncheon workshop from 12 to 1:30 pm, on Wednesday, May
21, 2008, in the Howe Room of the Loews Philadelphia Hotel.
Ziplex System for Focused Content, Multiplexed Gene-Expression Analysis --
Introduction and Study Results
David Englert, Ph.D., VP, Technology Development, Xceed Molecular,
Toronto.
Identification of a Diagnostic Classifier of Cornelia de Lange Syndrome,
an Often Misdiagnosed and Little-Known Genetic Syndrome, Through a Stepwise
and Multi-Platform Procedure
Zhe Zhang, Ph.D., Bioinformatics Core, Center for Biomedical Informatics,
Children's Hospital ofPhiladelphia
Dr. Zhe Zhang is also presenting a poster on the subject, which will be
available for viewing throughout the conference (Poster #11).
About Xceed Molecular
Xceed's vision is to advance molecular diagnostics by successfully
translating novel multiplex tests into routine clinical practice and to create
robust diagnostic solutions to improve disease outcomes. Our products comprise
the Ziplex(R) System for automated gene-expression analysis (available in the
US andCanada for research use only), gene expression services, and
pre-configured arrays. Xceed is also developing multiplexed genomic tests for
the Ziplex platform, both internally and with strategic partners. Xceed's R&D
and manufacturing are headquartered inToronto, Ontario, with executive
offices inWellesley, Massachusetts. For more information, visit
http://www.XceedMolecular.com.
SOURCE Xceed Molecular
Copyright © 2008, PRNewswire
Copyright © 2008, NewsBlaze,
Daily NewsTags: Pharmaceuticals, Biotechnology, Healthcare, , massachusetts, pennsylvania
_ _Is your favorite bookmark site missing?
Ask for it.
Search News
Daily News
